AimTab™ Reducing Substances Tablets – IVD Reducing Sugar Test

AimTab Reducing Substances Tablets IVD reducing sugar test for urine stool wine and other specimens
IVD | Clinical Chemistry | Urinalysis | Reducing Sugar Test

AimTab™ Reducing Substances Tablets

IVD tablet test for semi-quantitative determination of reducing substances

AimTab™ Reducing Substances Tablets are designed for the semi-quantitative determination of reducing substances, generally glucose, in urine, stool, wine, and other specimens.

The tablet method detects glucose and other reducing sugars, including lactose, fructose, galactose, and pentoses, making it useful for clinical, laboratory, teaching, wine, beverage, and specialty testing applications.

Urine Testing Stool Testing Wine & Beverage Labs Reducing Sugars IVD Reagent Tablets

Product Overview

AimTab™ Reducing Substances Tablets provide a practical, tablet-based method for screening reducing substances in clinical and laboratory samples. The product follows a Clinitest®-type testing procedure and is suitable for laboratories that require a simple semi-quantitative reducing sugar test format.

Clinical & IVD Use

Used for semi-quantitative determination of reducing substances in urine, stool, and other applicable specimens. Suitable for clinical chemistry and urinalysis-related laboratory workflows where reducing substance screening is required.

Wine & Beverage Testing

Applicable for wine, beverage, and fermentation-related laboratories that need a simple reducing sugar or residual sugar screening method for quality-control and educational use.

Distributor Opportunity

A niche laboratory product for distributors serving clinical labs, food and beverage labs, wineries, universities, veterinary laboratories, and specialty laboratory supply markets.

Key Features

  • Tablet-based reducing substances test
  • Semi-quantitative result interpretation
  • Detects glucose and other reducing sugars
  • Useful for urine, stool, wine, and other liquids/specimens
  • Room-temperature storage according to manufacturer instructions
  • Available in bottle and sealed pouch formats

Target Users

  • Clinical chemistry laboratories
  • Urinalysis laboratories
  • Pediatric and specialty screening labs
  • Food, beverage, and wine testing laboratories
  • University and teaching laboratories
  • Laboratory distributors and resellers

Available Packaging Options

Product Packaging Reference / Format Typical Application
AimTab™ Reducing Substances Tablets 36 tablets per bottle Bottled tablet format Clinical labs, urinalysis, teaching labs, winery and beverage laboratories
AimTab™ Reducing Substances Tablets 20 sealed pouches per box One tablet per sealed foil pouch Distributor resale, controlled single-use handling, field and specialty lab use
Application Note: AimTab™ reacts with reducing substances and is not specific only for glucose. Reducing sugars other than glucose, including lactose, fructose, galactose, and pentoses, may react positively. For glucose-specific testing or quantitative workflows, laboratories should select the appropriate glucose-specific test method or analyzer.
Safety Notice: AimTab™ tablets contain chemical reagents and must be handled only by trained personnel using appropriate laboratory safety practices. Follow the official package insert, SDS/MSDS, quality-control requirements, and local regulations. The product is not for internal use and must be kept away from children or untrained users.

International Supply & Distributor Support

GBT-EMEA supports laboratories, diagnostic distributors, winery laboratories, food and beverage testing labs, universities, and resellers with sourcing, documentation support, and bulk quotation for AimTab™ Reducing Substances Tablets.

Request Pricing, Availability, or Distributor Support

Contact us for current availability, expiration dating, documentation, reseller pricing, and international supply options for AimTab™ Reducing Substances Tablets.

Request Quote WhatsApp Inquiry

AimTab™ and related trademarks belong to their respective owners. Product availability, documentation, regulatory status, expiration date, and permitted use must be confirmed before order. For clinical or diagnostic use, buyers and distributors are responsible for confirming local IVD registration, import, labeling, and laboratory compliance requirements.